Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 5 of 5 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/30/11
End: 12/31/12
Due: 12/31/13
Phase: N/A
Priority: Normal
Start: 06/27/24
End: 03/31/26
Due: 03/31/27
Phase: N/A
Priority: Normal
Start: 04/30/16
End: 05/31/21
Due: 05/31/22
Phase: N/A
Priority: Normal
Start: 04/01/25
End: 10/01/26
Due: 10/01/27
Phase: N/A
Priority: Normal
Start: 07/27/23
End: 06/30/26
Due: 06/30/27
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Promotion of Self-help Strategies for Depression | NCT01399502 | Orygen | user2@example.com | None | 2011-11-30 | 2012-12-31 | 2013-12-31 | - | - | 2025-07-14 |
| Cognitive Behavioural Therapy for Avoidant/Restrictive Food Intake Disorder (CBT-AR) | NCT06463470 | Orygen | user2@example.com | None | 2024-06-27 | 2026-03-31 | 2027-03-31 | - | - | 2025-07-14 |
| The Staged Treatment in Early Psychosis Study | NCT02751632 | Orygen | user2@example.com | None | 2016-04-30 | 2021-05-31 | 2022-05-31 | - | - | 2025-07-14 |
| Hybrid Type 2 Implementation-Effectiveness Trial of a Third Wave Virtual Reality Treatment for Youth Depression/Anxiety | NCT06894836 | Orygen | user2@example.com | None | 2025-04-01 | 2026-10-01 | 2027-10-01 | - | - | 2025-07-14 |
| Guanfacine Extended-release for Adolescents With Cannabis Use | NCT05957848 | Orygen | user2@example.com | None | 2023-07-27 | 2026-06-30 | 2027-06-30 | - | - | 2025-07-14 |